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ABSTRACT We recently reported that the peptide C-K4-M2GlyR mimics the action of chloride channels when incorporated
into the apical membrane of cultured renal epithelial monolayers. C-K4-M2GlyR is one of a series of peptides that were
prepared by the addition of lysine residues to the N- or C-terminus of the M2 transmembrane sequence of the brain glycine
receptor. This study addresses how such modifications affect physical properties such as aqueous solubility, aggregation,
and secondary structure, as well as the ability of the modified peptides to form channels in epithelial monolayers. A graded
improvement in solubility with a concomitant decrease in aggregation in aqueous media was observed for the M2GlyR
transmembrane sequences. Increases in short-circuit current (ISC) of epithelial monolayers were observed after treatment with
some but not all of the peptides. The bioactivity was higher for the more soluble, less aggregated M2GlyR peptides. As
described in our previous communication, sensitivity of channel activity to diphenylamine-2-carboxylate, a chloride channel
blocker, and bumetanide, an inhibitor of the Na/K/2Cl cotransporter, was used to assess changes in chloride selectivity for
the different assembled channel-forming peptides. The unmodified M2GlyR sequence and the modified peptides with less
positive charge are more sensitive to these agents than are the more highly charged forms. This study shows that relatively
insoluble transmembrane sequences can be modified such that they are easier to purify and deliver in the absence of organic
solvents with retention of membrane association, insertion, and assembly.
INTRODUCTION
Recently we documented the effect of a C-terminally ad-
ducted sequence C-K4-M2GlyR (e.g., four lysine residues
added at the C-terminus) on cultured monolayers of epithe-
lial cells (Wallace et al., 1997). The aqueous soluble pep-
tide, derived from the transmembrane M2 segment brain of
the glycine receptor protein (Reddy et al., 1993), was ap-
plied to the apical surface of monolayers. The peptide has
been modeled as inserting into the apical membrane, then
associating to form ion-conducting pores that are composed
of four and five peptide helix bundles in a parallel orienta-
tion (Montal, 1995; Marsh, 1996). Anion fluxing channels
were produced, and transepithelial chloride secretion en-
sued. These channels were inhibited by the anionic channel
blockers niflumic acid, 5-nitro-2(3-phenylpropylamino)-
benzoate (NPPB), glibenclamide, and diphenylamine-2-car-
boxylate (DPC), and by omitting chloride from the media.
The effect of these peptides on Cl transport was not due to
an elevation in cellular cAMP content. The peptide-induced
chloride secretion causes a net increase in the rate of trans-
epithelial water secretion. The ability of epithelial tissues to
secrete chloride and water is compromised in cystic fibrosis
(CF) patients. Restoration of this activity through the addi-
tion of an easily synthesized and purified peptide might
have clinical applications in treating patients with cystic
fibrosis.
The C-K4-M2GlyR sequence was identified during the
study described herein. Our in vitro studies began with the
unmodified sequence but proved difficult to deliver reliably:
application of the peptide to the cells did not always result
in measurable channel activity. Each time the peptide solu-
tions were prepared, we observed that the degree of aggre-
gation of the peptide solution was variable and impossible
to control or predict. In the case of artificial bilayers, which
we employed in earlier studies (Reddy et al., 1993; Montal
et al., 1994), we overcame this problem by adding the
peptide to the lipids in organic solvents, dried the mixture,
and then formed bilayers with the peptides already associ-
ated with the lipids (Grove et al., 1991). Inclusion of organic
solvents to increase the solubility of the peptide was not an
option when studying living cells or tissues.
In this structure/activity study the effect of adding in-
creasing positive charge to either peptide terminus was
explored. Melittin, an unrelated membrane-active peptide,
was the paradigm used for the designs employed. Melittin is
best characterized as a detergent-like amphipath because of
its 20-residue transmembrane segment followed by a C-
terminal cationic hexapeptide tail with four positively
charged residues. The transmembrane segment is composed
of two helical regions divided by a central proline hinge.
Increased solubility is due directly to the presence of the
unstructured C-terminal hexapeptide that contains two ar-
ginine, two lysine, and two glutamine residues. Removal of
the hydrophilic residues results in a sequence that is only
33% as effective in inserting into membranes and nearly
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insoluble in water (Otada et al., 1992). Variants have been
synthesized in which the charged residues that occur at the
C-terminus have been transposed to the N-terminus (King et
al., 1994), or the net charge has been switched from positive
to negative (Ramalingam et al., 1992). All of these modi-
fications yielded active peptides. Clearly, the presence of a
highly charged terminus does not interfere with the lipid-
associating properties of the hydrophobic portion of the
molecule.
Furthermore, in a recent report (Englebretsen and Ale-
wood, 1996) a “solubilizing tail” strategy for rendering
hydrophobic peptides soluble in aqueous media was de-
scribed. The tail consisted of (Gly-Arg)4-Gly and was
placed at the C-terminus of a hydrophobic peptide by using
a cleavable glycoamide ester bond. The authors felt that the
method was general and that the attachment of this segment
to any hydrophobic sequence should render it more soluble
and easier to purify by standard high-performance liquid
chromatography (HPLC) protocols.
Although it may appear intuitive that adding charge to a
hydrophobic sequence will enhance its aqueous solubility,
this report represents the first study, to our knowledge, that
examines the biophysical and biological consequences of
the stepwise addition of positive charge to either terminus of
a membrane-spanning, channel-forming, amphipathic helix.
The solubility, degree of aggregation, channel activity, and
sensitivity to certain drugs were monitored for each succes-
sive modification in net charge at the C- and N-termini.
From these observations we draw hypotheses about the
modes of solubilization afforded by the added lysines.
EXPERIMENTAL
Peptide synthesis
All peptides were prepared using fluoren-9-ylmethoxy carbonyl (Fmoc)
chemistries on an Applied Biosystems model 431 peptide synthesizer
(Perkin-Elmer, Norwalk, CT) at a synthesis scale of 0.1–0.2 mmol, using
p-hydroxymethylphenoxymethyl polystyrene (HMP) resin preloaded with
the first amino acid, and with the degree of substitution calculated. For the
peptide C-K4-M2GlyR-CO-NH2, the resin 4-(2,4-dimethoxyphenyl-
Fmoc-aminomethyl polystyrene (Fmoc-amide resin) was used with the
degree of substitution calculated (0.64 mmol/g) (Perkin-Elmer). All sol-
vents were reagent grade unless otherwise indicated, and the protected
amino acids were purchased from one or more of the following vendors:
Perkin-Elmer, Bachem (Torrance, CA), Peninsula Laboratories (Belmont,
CA), and Peptides International (Louisville, KY). For the sequential N-
terminal modifications (N-K1–K6), aliquots were removed from a common
synthesis of the M2GlyR and M1CFTR sequences after each lysine residue
was condensed. For the C-terminal modifications, separate syntheses had
to be performed. All peptides, unless otherwise noted, were first HPLC
purified and then characterized through automated Edman degradation and
matrix-assisted laser desorption/ionization, time-of-flight mass spectral
analyses (MALDI-TOF-MS).
Solubility studies
Saturated solutions of the crude peptides in Ringer’s solution (pH 7.4:
OSM 305; 2.5 mM K2HPO4; 2.0 mM CaCl2; 1.2 mM MgSO4; 5 mM
glucose; 5.0 mM Na-acetate; 6 mM L-alanine; 1.0 mM Na3-citrate; 115
mM NaCl; 4.0 mM Na-lactate; 0.5 mM n-butyric acid; 20 mM NaHCO3;
14.1 mM raffinose) were prepared by dissolving increasing amounts of
peptide directly in 0.1 ml of the above solution until no more went into
solution. Samples were centrifuged for 3 min at 15,000  g, and the
supernatant was analyzed for protein concentration with the Pierce BCA
protein assay. With the higher lysine analogs, K4–K6, a clear gel often
formed at saturating concentrations. In those cases, just enough fluid was
added to these solutions to break the gels.
HPLC studies
Reverse-phase HPLC (PLRP-S300; 50  7.5 mm I.D.), with a linear
10-min gradient from 20% to 70% acetonitrile in water containing 0.1%
trifluoroacetic acid, was used to check for aggregation in the soluble
peptide fractions (Figs. 2 and 3) prepared above. Ten microliters of the
soluble layer from the solubility studies above was injected. The concen-
trations of those peptides differed in each case and are indicated in Table
1. Elution from the column was monitored at 215 nm. HPLC-purified
samples were used for the in vitro assays and biophysical studies. The
crude samples were dissolved in water containing 50% acetonitrile at
concentrations of 5 mg/ml. Under these conditions the peptides did not
aggregate to any great extent. These purified samples were taken to dryness
under vacuum. NMR and circular dichroism (CD) samples were dissolved
in water or D2O as required.
Bioactivity of modified peptides
We investigated the channel-forming activity of M2GlyR and the lysine
analogs (N- and C-termini) on monolayers of subtype of Madin-Darby
canine kidney (MDCK) cells (Grantham et al., 1989) grown on permeable
supports (Snapwell, 12-mm diameter; Costar Corp) (Mangoo-Karim et al.,
1995). MDCK monolayers were placed in Ussing chambers containing 5
ml of Ringer’s medium in the apical and basolateral compartments. The
short-circuit current (ISC) was measured 30 min before and up to 1 h after
the addition of the peptide. The unmodified M2GlyR and the N-K1-
M2GlyR were dissolved in dimethyl sulfoxide (DMSO) because of the low
solubility of these peptides in aqueous solutions. The maximum final
concentration of DMSO (1%) was without effect on ISC. More soluble
forms of M2GlyR were prepared as 2.5 mM stocks in Ringer’s medium. In
inhibitor experiments, either basolateral bumetanide (100 M) or apical
DPC (3 mM) was added after ISC reached a steady state (usually 40 min)
in the presence of the peptide. As an example (Fig. 1), bar graphs for the
effect of C-K4 M2GlyR (100 mM) on the MDCK monolayers are shown,
as is the relative inhibition afforded by the addition of the two inhibitors,
bumetanide and DCPC.
Circular dichroism and NMR studies
CD was used to monitor the secondary structure of N-K4-M2GlyR and
C-K4 M2GlyR in water at 25°C (with and without trifluoroethanol (TFE)
10–40%). Spectra were recorded on a Jasco J-720 spectropolarimeter with
a Neslab RTE-111M circulator using a cylindrical, water-jacketed, quartz
cuvette with a 0.1-mm pathlength. The plots are an average of 8 scans,
recorded at a rate of 20 nm/min. Peptide concentrations of 0.1–1.5 mM
were employed. Protein concentrations were determined using the Pierce
BCA micro-protein assay, with bovine albumin used as the standard. The
data were analyzed with software provided by the manufacturer. A simple
unfolding experiment was also performed: spectra for N-K4-M2GlyR and
C-K4 M2GlyR were recorded at 25, 30, 37, 45, 50, 60, and 70°C. After the
spectra were taken for both peptides at a given temperature, the water bath
temperature was raised to the next higher temperature and then allowed to
equilibrate for 30 min. Spectra using 8 scans were recorded, and then the
temperature elevation and equilibration process was repeated.
NMR was used to examine aggregation. TOCSY spectra were generated
in water containing 10% D2O and 30% deuterated TFE for the N-K0-K6
M2GlyR series, C-K4-M2GlyR, and C-K4-M2GlyR-CO-NH2. Peptide con-
centrations of 3.0 mM were used to generate all spectra. Two-dimensional
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spectra were performed with a 11.5-T Varian Utilityplus spectrometer
operating at 499.96 MHz for 1H, with a 5-mm triple-resonance inverse
detection probe. NMR data sets were collected at 30°C. A total of 256
increments of 2K data points were recorded with 100 ms mixing time. All
data sets were collected in hypercomplex phase-sensitive mode and were
processed and analyzed using Varian NMR software VNMR 5.2b on a
Silicon Graphics workstation. Before processing, the t1 dimensions of data
sets of all experiments were zero-filled to 2K. When necessary, spectral
resolution was enhanced by Lorentzian-Gaussian apodization.
Viscosity measurements
Peptide samples were dissolved in Ringer’s solution (pH 7.4) or water at
the indicated concentrations to a final volume of 4.0 ml. Samples were
vortexed for 15 s, centrifuged at 4000  g for 1 min, transferred to an
Ostwald 100 viscometer immersed in a 37°C circulating water bath, and
allowed to come up to temperature. The first time point was usually
recorded at 10 min. At each incubation point, three readings were taken
and an average value (t) was determined. The viscosity () was calculated
as the product of the time (t), the density () of the sample solution, and
the viscometer constant (A). In those experiments in which shear was
observed, only the first time point taken was used for the viscosity
calculation.
RESULTS
Several families of peptides based on the M2 transmem-
brane segment of the brain glycine receptor (M2GlyR) and
the M1 transmembrane segment of the human cystic fibrosis
transmembrane conductance regulator protein (M1CFTR)
sequences (Table 1) were prepared. The table includes the
sequences of the peptides, along with the net increase or
decrease in overall charge of the peptide and the solubility
in Ringer’s buffer (given in both mg/ml and mM as the
molecular weights of the adducted peptides). The M2GlyR
sequence is classified as a channel-forming amphipathic
helical segment, whereas the M1CFTR sequence, used as a
control, is composed almost exclusively of hydrophobic
residues, which is considered to be more typical of a trans-
membrane sequence. The M1CFTR peptide associates with
membranes but does not appear to form an ionic conducting
channel like M2GlyR (Montal et al., 1994). The low intrin-
sic solubilities of the two unmodified transmembrane seg-
ments, 1.4 mM for M2GlyR and 0.26 mM for M1CFTR in
Ringer’s solution, reflect their membrane origin. The am-
phipathic sequence, M2GlyR, has a higher hydrophobic
moment and is somewhat more soluble than M1CFTR. As
one of the controls, the M2GlyR sequence was scrambled.
In designing this scrambled sequence, we minimized any
amphipathic structure or -inducing structure.
Effects of N-terminal peptide modifications
on solubility
Modifications that yielded net charges of  2 at the
N-terminus of wild-type M2GlyR sequence and4 at the
N-terminus of M1CFTR did not significantly improve the
aqueous solubility of the parent sequence. Nor did the
TABLE 1 Solubility of modified membrane sequences
M2GlyR modification  charge mg/ml mM MW
Wild type: PARVGLGITTVLTMTTQSSGSRA 0 3.3 1.4 2305
N-Ac- 1 3.4 1.4 2353
N-Ac-DAP 0 4.1 1.68 2439
N-DAP 1 4.1 1.7 2391
N-Lys-DAP 2 4.3 1.7 2519
N-K1 1 4.1 1.7 2433
N-K2 2 6.9 2.3 2561
N-K3 3 29.8 11.1 2689
N-K4 4 37.8 13.4 2817
N-K5 5 46.4 15.8 2946
N-K6 6 64.9 21.1 3074
C-K3 3 27.2 10.1 2689
C-K4 4 77.8 27.5 2817
C-K4-CO-NH2 5 158 56.1 2815
C-K5 5 147 49.9 2946
Scrambled: ILASTRSQTGRMALSGTTTPGVV 0 152 66 2305
Scrambled C-K4 4 248.9 88 2817
M1CFTR modification
Wild type: RFMFYGIFLYLGEVTKAVQPLLLG 0 0.69 0.26 2620
N-K1 1 0.73 0.27 2748
N-K2 2 0.73 0.25 2876
N-K3 3 0.92 0.31 3004
N-K4 4 1.0 0.32 3132
N-K5 5 38.8 11.9 3260
N-K6 6 72.1 21.3 3389
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complete removal of charge from the N-terminus of
M2GlyR alter the solubility. Reverse-phase HPLC and
MALDI-TOF-MS confirmed that M2GlyR and M1CFTR
form aggregates in Ringer’s buffer. This buffer was used
because of its requirement in the electrophysiological ex-
periments on cultured kidney epithelium monolayers. The
HPLC profiles for the M2GlyR and M1CFTR series are
shown in the first panel of Figs. 2 and 3, respectively.
Aggregated peptides appeared as multiple broad peaks that
eluted slowly with increasing organic mobile phase.
MALDI-TOF-MS analyses of samples, taken anywhere under
the broad peaks, revealed only the mass of the monomers.
A graded simplification in the HPLC profiles was ob-
served as the number of lysine residues added to M2GlyR
was increased. With the addition of the third lysine, essen-
tially a single peak eluted. Beyond the addition of the third
lysine (net charge  3 at neutral pH) to M2GlyR, solu-
bility increased further (Table 1), although no additional
changes were observed in the HPLC elution profile. It is
somewhat surprising that the further addition of lysines did
not alter the retention time of the apparent monomeric
peptide, and this leads us to postulate that the bulk of the
FIGURE 1 Effect of C-K4-M2GlyR on ISC and the subsequent effect of
Cl transport inhibitors. C-K4-M2GlyR (100 mM) was added to the apical
surface of MDCK monolayers after a 30-min control period. Forty minutes
later, either bumetanide (100 mM) was applied to the basolateral surface or
DPC (3 mM) was added to the apical surface. (A) Effect of C-K4-M2GlyR
and subsequent effect of bumetanide, an inhibitor of the Na-K-2Cl trans-
porter. The bar graph represents the average of 31 separate monolayers
(N  31). (B) Effect of C-K4-M2GlyR and the subsequent effect of DPC,
a Cl channel blocker (N  5).
FIGURE 2 From a single chemical synthesis, six lysines were added in
sequence to the N-terminus of M2GlyR. Aliquots were cleaved and
checked for solubility in Ringer’s solution, and the RP-HPLC pattern was
determined. Increased solubility correlated well with the stepwise addition
of lysine 3 and beyond. The HPLC pattern also simplified, indicating a
gradual shift from aggregate toward monomer.
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FIGURE 3 From a single chemical synthesis, six lysines were added to the N-terminus of M1CFTR. Aliquots were cleaved and checked for solubility
in Ringer’s solution as well as the RP-HPLC pattern. Increased solubility correlated well with the stepwise addition of lysine 5 and 6. Note that the transition
toward monomer was much more abrupt for this sequence.
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interaction with the RP-HPLC matrix was occurring via the
hydrophobic portions of the molecule and not the positively
charged lysines. However, the solubility of the nonam-
phipathic control sequence, M1CFTR, changed little
through the addition of the fourth lysine, improving from
0.26 mM to only 0.32 mM. With the addition of the fifth
lysine, a 37-fold increase in solubility was seen over that of
the K4 adduct, and the HPLC profile dramatically collapsed
to essentially one peak. Increases in solubility due to the
addition of the third lysine for M2GlyR (4.8-fold) and the
fifth lysine for M1CFTR (34-fold) appeared to be cooper-
ative in nature (Fig. 4 A). In addition to the increased
solubility, the incorporation of lysines at the N-terminus of
the two sequences apparently decreased the degree of ag-
gregation, as judged by the HPLC profiles (Fig. 2).
To assess the degree of aggregation for the soluble pep-
tides, TOCSY-NMR was used. Because NMR linewidths
are related to the rotational correlation time of the peptide,
monomers, being the smallest rotational unit, will have the
sharpest linewidths, whereas aggregates, by virtue of their
larger size and slower rotation, will have much broader
linewidths. Other groups have used NMR effectively to
examine aggregation (Hwang et al., 1988; Yang et al., 1994;
Jayakumar et al., 1995; Altieri et al., 1995). Because of the
complexity of the 1D proton spectra, we chose to use a 2D
technique to assess the degree of aggregation. We generated
the TOCSY spectra for all peptides (3.0 mM) in 30%
deuterated TFE in water and examined the resolution of the
CH/NH connectivity signals. In these spectra, aggregated
peptides generated signals that appeared smeared and over-
lapping, as opposed to monomeric peptides, which yielded
discrete, well-defined signals. Based on the HPLC tracings,
it seemed reasonable to expect that N-K3 through N-K6-
M2GlyR would all be monomeric by virtue of their single
sharp HPLC peaks. However, the TOCSY-NMR spectra for
the sequences revealed qualitatively different levels of ag-
gregation. N-K0–3 all appeared to be aggregated because of
their many broad overlapping signals. N-K4 appeared less
aggregated, whereas N-K5 and N-K6 were judged to be
essentially monomeric because of the presence of well-
resolved, nonoverlapping signals. Representative spectra re-
corded using N-K0-, N-K3-, and N-K5-M2GlyR are shown
in Fig. 5. Although the sample preparation for the two
systems, HPLC and TOCSY-NMR, are not identical, we
believe that the comparison is still valid. HPLC elution
profiles generated for the N-K3 peptide that was dissolved
in the absence of salts in 30% TFE/water showed an even
better resolved profile (sharper and less broad) than that
seen for peptide in Ringer’s, as shown in Fig. 2. This
observation suggests that TFE/water dissolved an even less
aggregated preparation, yet when probed by the NMR tech-
nique, this sample reveals broadened signals characteristic
of aggregated samples. The observation that N-K3 appears
monomeric by HPLC (conditions that yield a more aggre-
gated mixture) yet aggregated by NMR (prepared using
conditions that generate a less aggregated solution) suggests
that NMR is clearly the more sensitive of the two tech-
niques.
Effects of C-terminal modifications on
M2GlyR solubility
Selected modifications at the C-terminus were also studied
(Table 1). This C-terminal series contained sequences with
three to five positive charges added. The effect of adding
positive charge at the C-terminus was much more dramatic
than that observed for the N-terminus (Fig. 4 B). The
wild-type sequence with its free C-terminus was used for
the 0.0 net charge values for the C-terminal modification.
The C-K3 adduct’s solubility was equivalent to that seen for
N-K3. However, placing four lysines at the C-terminus for
C-K4 peptide led to a solubility in excess of that seen for the
N-terminal adduct, N-K6. The C-terminal 5 species were
generated as the C-K5 analog or by synthesizing the C-K4
peptide on a resin that placed the carboxamide at the C-
terminus, thus neutralizing the negative charge. These pep-
tides were extremely soluble, achieving levels of 147 mg/ml
(49.9 mM) and 158 mg/ml (56.1 mM), respectively. This
FIGURE 4 (A) The increase in solubility is plotted against the number of
lysines added to the N-terminus of M2GlyR (F) and M1CFTR (Œ). A
single synthesis was carried out for each sequence, with aliquots taken after
the addition of each new lysine. Both solubilizations appear to be cooper-
ative. The amphipathic M2GlyR sequence was solubilized with less added
lysines. (B) The increase in solubility is plotted against the number of
maximum positive charges added to the N- or C-terminus of M2GlyR. A
single synthesis was carried out for each sequence, with aliquots taken after
the addition of each new lysine for the N-K series (F), and separate
syntheses required for each of the C-K series (E).
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FIGURE 5 TOCSY NMR for selected sequences
of the N-K series of M2GlyR at 3 mM in water
containing 10% D2O and 30% deuterated TFE. Only
a portion of the TOCSY spectra (CH/NH connec-
tivity region) is shown, for greater detail. Note that
only the K5 adduct appears monomeric, based on the
well-resolved cross-peaks.
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represented about a 40-fold increase in solubility compared
to the nonmodified peptide. The paradox here, in which
similar increases in net charge (4 and 5) at the C-
terminus yield peptides that are twice as soluble as the
analogous N-modified peptides, suggests that either modi-
fications to the C-terminus yield more monomer per given
charge or that the C-K4 aggregate species have higher
solubility.
TOCSY-NMR spectra suggested that the latter hypothe-
sis is correct. NMR revealed that C-K3 was aggregated,
C-K4 appeared to be a mixture of monomer and aggregate,
whereas C-K4-CO-NH2 and C-K5 were predominantly mo-
nomeric. The NMR data suggested that the C-Kn series
behaves just like the N-Kn series with regard to aggregation.
This finding indicates that although the relative solubility of
the C-Kn series was much greater (Fig. 4 B), it was still
apparently aggregated to the same extent. The aggregates
formed by modifying the C-terminus were apparently more
soluble than those produced with the N-K series.
Channel-forming activity of M2GlyR peptides
Channel-forming activity of the solubilized N-Kn-M2GlyR
sequences in a subtype of MDCK cells was assessed. These
cells were grown to confluent monolayers on permeable
membranes. The monolayers were inserted into Ussing
chambers, and the applied external current required to drive
the negative transepithelial potential difference to zero
(short-circuit current, ISC) was measured (Wallace et al.,
1997). The opening of native anion channels in the apical
membrane of the cells or the insertion of foreign, anion
channel-forming peptides results in an increase in positive
current flow from the apical to the basolateral surface of
these monolayers (Wallace et al., 1997; Mangoo-Karim et
al., 1995).
Because of its low solubility in aqueous media, the un-
modified M2GlyR sequence was dissolved in DMSO. This
solution was added to the medium bathing the apical surface
of the monolayers in amounts that achieved a final concen-
tration of 100 M peptide and 1% DMSO. Under these
conditions, an increase in ISC was recorded in only 65% of
the monolayers tested. In these monolayers, an increase in
ISC of 1.0 	 0.1 A/cm
2 was observed (Table 2). N  24
indicates the number of individual monolayer experiments
that were averaged to generate this ISC value and standard
deviation. This stimulated ISC was inhibited by the Na-K-
2Cl cotransporter blocker, bumetanide, applied to the baso-
lateral surface and by the chloride channel blocker DPC
applied to the apical surface. These electrophysiological and
pharmacological effects served as the standard for evaluat-
ing the modified sequences.
Peptides modified by the addition of one, two, or three
lysines at the N-terminus underwent little enhancement of
channel-forming activity. However, the addition of lysines
4, 5, and 6 improved the magnitude and reliability of the
induced changes at each step (Table 2). The increases in ISC
for the N-K series ranged from 0.3 A/cm2 (for N-K1) to
3.3 A/cm2 (N-K6), compared to 1.0 A/cm
2 for the un-
modified M2GlyR. The frequency of producing chloride
channel activity improved to a point that every experiment
yielded increases in ISC, increasing from a frequency from
65% for the unmodified sequence to 100% for N-K4-,
N-K5-, C-K4-, and C-K4-carboxamide. The wild types, N-
K4–N-K6, were tested for their response to bumetanide and
DPC. As shown in Table 2, the N-K4 completely retained
the pharmacological characteristics demonstrated by the
unmodified M2GlyR peptide. The N-K4 channel activity
was also inhibited by omitting chloride from the bathing
media (data not shown). Although the highly soluble N-K5-
and N-K6-M2GlyR yielded increased ISC, the ISC values
were much less sensitive to the presence of the two inhib-
itors. The lack of response to bumetanide, which blocks
chloride entry into the cell at the basolateral surface, sug-
gested that chloride selectivity may have been lost.
Channel-forming activities for C-K3-, C-K4-, C-K5-, and
C-K4-CO-NH2 analogs were also investigated. Despite its
increased solubility, TOCSY-NMR indicated that the C-K3
analog was aggregated in solution. This peptide also
showed little additional effect on the MDCK monolayers
compared to the wild-type sequence. The C-K4 analog,
which was more soluble than the 7 charged N-K6-
M2GlyR sequence, exerted a much greater effect on ISC
than did N-K4 and retained the pharmacological responses
of the wild-type, unmodified sequence. The C-K4-M2GlyR-
CO-NH2 and C-K5-M2GlyR had the highest solubilities of
any of the M2GlyR adducts, but paradoxically displayed
TABLE 2 Physiological effects of selected N- and C-modified M2GlyR peptides
Peptide Frequency of activity (%) ISC increase (A/cm
2) Bumetanide (% inhibition) DPC (% inhibition)
M2GlyR 65 (N  37) 1.0 	 0.1 (N  24) 100 (N  5) 100 (N  5)
N-K1-M2GlyR 42 (N  12) 0.3 	 0.0 (N  5) 100 (N  3) 100 (N  2)
N-K2-M2GlyR 67 (N  12) 0.9 	 0.2 (N  8) 96 (N  4) 99 (N  4)
N-K3-M2GlyR 80 (N  10) 0.6 	 0.1 (N  8) 55 (N  4) 87 (N  4)
N-K4-M2GlyR 97 (N  58) 1.2 	 0.1 (N  56) 69 (N  29) 97 (N  5)
N-K5-M2GlyR 100 (N  13) 2.8 	 0.4 (N  13) 37 (N  5) 22 (N  6)
N-K6-M2GlyR 100 (N  10) 3.3 	 0.6 (N  10) 10 (N  5) 22 (N  5)
C-K3-M2GlyR 91 (N  11) 1.1 	 0.3 (N  10) 99 (N  4) 61 (N  6)
C-K4-M2GlyR 100 (N  94) 2.7 	 0.2 (N  94) 77 (N  31) 93 (N  5)
C-K4-M2GlyR-carboxamide 100 (N  14) 1.2 	 0.2 (N  14) 99 (N  6) 77 (N  5)
C-K5-M2GlyR 83 (N  12) 0.8 	 0.1 (N  10) 58 (N  5) 58 (N  5)
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lower channel-forming activities. This result suggested that
these two forms have decreased affinity for the membrane.
Of the modified peptides listed in Table 2, C-K4-M2GlyR
gave the greatest increase in ISC while retaining a near-
normal response to bumetanide and DPC. C-K1 and C-K2
were not prepared, because of the expense of generating two
peptides, which we felt would be uninteresting because of
the relative activity of C-K3-M2GlyR. The C-K6 derivative
of M2GlyR was not prepared because of the reduced ISC
observed with both C-K4-M2GlyR-CO-NH2 and C-K5-
M2GlyR.
For the in vitro assay activity controls, a scrambled C-
K4-M2GlyR sequence was generated (Table 1). The scram-
bled wild-type sequence yielded a 47-fold increase in sol-
ubility over the native amphipathic sequence. The addition
of the four lysines increases its solubility by 63-fold over
the native M2GlyR sequence but by only 3.2-fold more than
the C-K4 adduct. The C-K4 scrambled sequence, however,
failed to produce channel activity in MDCK cells. Addition
of the five lysines to M1CFTR, a sequence that previously
was shown to be unable to form channels (Montal et al.,
1994), resulted in a modest rise in ISC (0.4 A/cm
2; N 2).
Although this activity appears as good as several of the
M2GlyR adducts, we have no knowledge of the ion selec-
tivity, single channel conductance, or pharmacology. This
result simply eliminated this peptide as a suitable control
sequence.
The sequences C-K4-M2GlyR and N-K4-M2GlyR were
tested for an effect on fluid secretion in experiments in
which monolayers were incubated for 24 h with 500 M
peptide. The monolayers exposed to C-K4-M2GlyR se-
creted fluid at a rate of 0.15 	 0.02 l/h/cm2 (N  8) (the
rate for paired control monolayers was 0.01 	 0.02 l/
h/cm2; p 
 0.01). The rate of fluid transport by monolayers
incubated with N-K4 did not differ from the control rate
(0.0 	 0.02 l/h/cm2, N  8).
Circular dichroism analysis of peptide
secondary structure
CD studies were initiated to identify any structural differ-
ences between two best sequences, C-K4-M2GlyR and N-
K4-M2GlyR. CD spectra of N-K4 and C-K4 were recorded
at varying concentrations in water (100 mM, 500 mM, 1
mM, and 1.5 mM). The spectra were all remarkably similar,
each showing one strong minimum at 197 nm. However,
because the spectra were not superimposable, we suspect
that there are slight differences in the degree of random coil
or degree of aggregation. No concentration-dependent
changes in the CD spectrum were observed over the con-
centration range tested (data not shown). A gradual transi-
tion from random coil was observed as the percentage of
trifluoroethanol (TFE) was increased. The peptide displayed
high helical content at 30% TFE in water, with a slight
increase in helicity when the TFE concentration was in-
creased to 40%. In Fig. 6, the CD spectrum for the 0.5 mM
concentrations of N-K4 and C-K4 are shown in the presence
and absence of 40% TFE in water. At this TFE concentra-
tion (Fig. 6) the CD spectra for the two peptides are essen-
tially identical and indicate that they both form about the
same amount of helix, estimated to be 60% based mean-
residue ellipticity at 222 nm (Chen et al., 1974). CD was
also employed for a temperature study in 40% TFE. Spectra
were taken from 25°C to 70°C in hopes of seeing which of
the N- or C-K4 sequences unfolded at a lower temperature.
Both adducts, however, retained their full structure up to
and including the highest temperature tested.
Viscosity measurements of peptide
aggregation rates
The effects of salt on aggregation were tested by monitoring
changes in the viscosity of C-K4-M2GlyR and N-K4-
M2GlyR solutions. Relatively high concentrations of pep-
tide were employed to yield measurable rates. From NMR
experiments conducted in the absence of salt, we know that
these samples at 3 mM are already partially aggregated. The
time dependence of aggregation in Ringer’s buffer (at pH
7.4) and water is shown (Fig. 7). In water, no increase in
viscosity was observed for either C-K4-M2GlyR or N-K4-
M2GlyR. However, in the presence of Ringer’s, further
aggregation was promoted. Different modes and rates of
aggregation were seen for 4.67 mM C-K4-M2GlyR and 4.67
mM N-K4-M2GlyR in Ringer’s solution. The kinetics of
C-K4-M2GlyR aggregation were best described as a first-
order reaction, whereas those of N-K4-M2GlyR were sec-
ond order. At 2.33 mM, N-K4-M2GlyR aggregated at a
fourfold slower rate, thus confirming the second-order pro-
cess for the N-K4 peptide. The reasonable fits for the the-
oretical curves and the data further support this claim. In the
bioassays performed using concentrations of peptide in the
FIGURE 6 CD spectra for 0.5 mM solutions for selected M2GlyR se-
quences: C-K4 in water (), C-K4 in water containing 40% TFE (‚), N-K4
in water (f), and N-K4 in water containing 40% TFE (Œ).
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100–200 mM range in Ringer’s, the rate of aggregation
would be negligible over the time course of the experiment.
One experiment was performed that included 40% TFE
along with the Ringer’s to test the rate of aggregation of
helical segments as opposed to the random coils seen for
Ringer’s alone. Unfortunately, the rate of aggregation was
too rapid to be measured accurately using our viscometer.
DISCUSSION
The lack of solubility of channel-forming amphipathic pep-
tides is a problem that we previously had to endure (Reddy
et al., 1993; Grove et al., 1991; Montal et al., 1994;
Iwamoto et al., 1994). Not only is this class of peptides
relatively insoluble, the limited amount of peptide that does
dissolve does so in an aggregated state. Other channel-
forming peptides, such as -toxin, have been shown to form
aqueous aggregates comprising 70 molecules (Kantor et
al., 1972), whereas [Ala14]-melittin analog formed aggre-
gates containing 50 molecules (John and Jahnig, 1992).
To overcome this intrinsic property, 16 separate modified
M2GlyR peptides were designed, synthesized, and analyzed
with regard to their aqueous solubility, degree of aggrega-
tion, and bioactivity. Peptides were modified by varying the
net positive charge at either the N- or C-terminus of the
peptide. The complete removal of charge from the N-ter-
minus of M2GlyR did not alter the solubility, suggesting
that the amphipathic character of the segment is driving its
limited solubilization.
We postulated that by adding positive charge to either
terminus, a water-soluble channel-forming sequence could
be developed that ideally produces channels each time it is
presented to membranes, while preserving the channel prop-
erties of the relatively insoluble unmodified sequence. Sev-
eral criteria were used to evaluate the effect of the added
charges. We first assayed the solubility at saturation of the
different peptides in buffer at neutral pH. We then checked
the aggregation state of the solubilized sequences by using
HPLC and TOCSY-NMR. In addition, we measured elec-
trophysiological and pharmacological parameters to try and
correlate solubility and degree of aggregation to bioactivity.
These experiments clearly demonstrated that adding more
charge promoted increased solubilization. Addition of the
third lysine to the N-terminus of M2GlyR led to a cooper-
ative effect that greatly enhanced solubility. However, this
enhanced solubility did not appear to correlate directly with
bioactivity. Some lysine-modified sequences such as N-K3-
M2GlyR, which showed a dramatic increase in solubility
over the unmodified sequence, had poor activity when
tested in the MDCK monolayers. In contrast, N-K4-
M2GlyR, which was only slightly more soluble than N-K3,
showed good activity with the cultured cells. Thus solubil-
ities alone do not account for the differences in channel
activity for these two compounds.
Based on the HPLC profiles for the different peptides,
increasing the number of charged residues at either terminus
decreased the apparent amount of aggregation. For the un-
modified and modified sequences of M2GlyR containing
fewer than two lysines, the elution profile contained numer-
ous broad and poorly resolved peaks. This profile suggested
a mixed population of aggregates of varying sizes. The
elution profiles for lysine adducts of M2GlyR containing
three or more lysines were sharp, well resolved, and late
eluting. The apparent transition from aggregated to less
aggregated or monomeric states seen in the HPLC pattern
correlated well with the cooperative step seen in the solu-
bilization studies.
The TOCSY-NMR data suggested that the transition seen
in the HPLC profiles most likely reflects a transition from a
high aggregation to a reduced aggregation state. N-K0–2-
M2GlyR formed complex aggregates that were detectable
by HPLC and NMR and gave poor results in the bioassays.
The HPLC profile N-K3 peptide appeared identical to that
seen for the N-K4–6-adducts, yet this fraction appeared
more aggregated by TOCSY-NMR than the others and
failed to reliably stimulate ISC to the degree that the others
did. The most logical conclusion is that N-K3-M2GlyR
forms small aggregates that are readily soluble in aqueous
systems yet interact poorly with membranes, thus producing
no functional channels. Peptides N-K4 through N-K6 were
highly soluble, contained differing percentages of monomer
in water containing 30% TFE (as judged by NMR), and
always produced an increase in short-circuit current (ISC).
In reconciling the solubility and activity data as well as
the TOCSY-NMR spectra and HPLC profiles, three differ-
ent states of association appear to exist for the peptide,
depending on the amount of positive charge added to the
sequence. In solutions of the wild type, N-K1 and N-K2-
M2GlyR, larger aggregates predominate that are relatively
FIGURE 7 The changes in viscosity with time for the N-K4 and C-K4-
M2GlyR peptides were followed in Ringer’s (with salt) and water (without
salt). Samples were as follows: N-K4-M2GlyR in Ringer’s, 4.67 mM (F),
2.34 mM (f); N-K4-M2GlyR in water, 4.67 mM (); C-K4-M2GlyR in
Ringer’s, 4.67 mM (Œ); C-K4-M2GlyR in water, 4.67 mM (). The actual
data points are shown, and the curves represent the theoretical plots for
first- and second-order processes.
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insoluble in aqueous buffers. We suspect that solutions
containing these peptides contain few if any monomers.
N-K3-M2GlyR forms smaller aggregates that are relatively
soluble (up to 11 mM). Yet these peptides still yield poorly
resolved TOCSY-NMR spectra and are relatively inefficient
in forming active channels in epithelial cells. The coopera-
tive effect seen in solubility, jumping from 2.3 to 11.1 mM
for N-K3-M2GlyR, reflects the break-up of the large aggre-
gates into smaller aggregates that have the same retention
time as monomer on reverse-phase HPLC. In aqueous so-
lutions of C- and N-K4-M2GlyR, small aggregates are ap-
parently mixed with monomers that almost always generate
channel activity. This transition occurs over a small change
in solubility, occurring somewhere between 11.1 and 13.4
mM for N-Kn-M2GlyR series. Monomer predominates
when the fifth lysine is added. In terms of solubility, the
mixed form gives way to monomer between 13.4 and 15.8
mM. The differences in solubility of the different aggrega-
tion states reflect the free energies required to not only
solvate the peptides but also to overcome solute-solute
hydrophobic interactions. We hypothesize that the cooper-
ative step in going from large aggregates to small aggre-
gates reflects breaking of the solute-solute hydrophobic
interactions.
These results suggest that HPLC profiles are not sensitive
for detecting the smaller aggregates seen in our system. In
a comparison of these two techniques, we found increased
sensitivity with multidimensional NMR. The results of the
NMR work allowed us to formulate the hypothesis that an
increase in monomers leads to high activity. By examining
the resolution of the individual TOCSY-NMR resonances,
one can better estimate aggregation compared to analyzing
HPLC profiles.
The addition of positive charge to the C-terminus results
in sequences that are considerably more soluble than their
N-K-M2GlyR counterparts (Table 1). The nonequivalence
of placing the same net charges at the C-terminus versus the
N-terminus suggests that the peptides are asymmetrical in
one or more properties. CD of the N-K4- and C-K4-M2GlyR
shows them to be unstructured to a similar degree in water.
However, N-K4- and C-K4-M2GlyR appear to adopt the
same helical conformation in 40% TFE, and these structures
appear to be stable to the same degree from 25°C to 70°C.
Based on the viscosity studies, electrostatic repulsion
between the positively charged tails of the modified
M2GlyR peptides was responsible for their increased solu-
bility. Shielding of the added positive charge through the
addition of mono- and divalent anions leads to increased
aggregation. Ringer’s buffer contains several divalent an-
ions, such as phosphate, sulfate, and citrate, that might
interact with one or more lysine residues. The addition of
the divalent phosphate anion to melittin promotes aggrega-
tion (van-Veen et al., 1995). However, differences in ag-
gregation rates of high concentrations of C- and N-K4-
M2GlyR in Ringer’s and in water indicate that adding
charge to the C- and N-termini yields modified peptides
with different properties. The difference in the rate orders
(first for C-K4 and second for N-K4) suggests that the
assembly of aggregates is different for the two forms.
MDCK cells incubated with 100 M C-K4-M2GlyR
reach maximum activation after 30–40 min, indicating that
channel assembly is not spontaneous. After reaching max-
imum activity, if the medium containing the peptide is
replaced with fresh peptide-free medium, activity begins to
drop off immediately, and by 2 h no measurable increase in
ISC is seen. This result suggests that the peptide may estab-
lish an equilibrium between membrane-bound and free
monomer in the extracellular buffer fractions. Thus the
lower activity seen with the highly soluble C-K5- and C-
K4-CO-NH2-M2GlyR peptides may be due to such an equi-
librium, which favors the free monomer in solution.
Once the monomeric peptide binds to the apical mem-
brane of the MDCK cells, it must orient relative to the end
of the peptide that is modified with the charged tail. Both
the C 3 N and N 3 C orientations of the assembled
peptides yielded functional channels that were inhibited by
DPC. We believe that because of the high energy barrier
that exists for translocating the positively charged tail across
the membrane, it is unlikely that the peptide enters the cell.
The observation that C-K4 exerted a greater effect on ISC
than N-K4 suggests that the C-terminal modification may
yield a more favorable orientation.
Our success in solubilizing the nonamphipathic M1CFTR
sequence suggests that other transmembrane sequences can
benefit from this approach. We suspect that most types of
transmembrane sequences could be made soluble in aque-
ous buffers. A different group reported similar increases in
solubility and activity when increased positive charge was
added to peptide–magainin-2 (Bessalle et al., 1992). The
major difference between the solubilization of M1CFTR
and M2GlyR observed through the addition of lysine resi-
dues is the transition between insoluble and soluble forms.
The solubility of M2GlyR gradually increases up to the
addition of the third lysine, with a gradual decrease in the
complexity of the HPLC elution pattern, whereas the
M1CFTR appears essentially unchanged. We suspect that
for some very hydrophobic peptides, solubilization could
compromise bioactivity. We feel this is a distinct possibil-
ity, based on the altered activity observed when the fifth and
sixth lysines were added to M2GlyR.
CONCLUSIONS
The desire to find a water-soluble, Cl-specific, channel-
forming peptide was the driving force behind this study.
Using the structure of melittin as a model, we added suffi-
cient positive charge to the N- or C-terminus of the M2
transmembrane segment of the glycine receptor, to increase
its solubility in aqueous media through electrostatic repul-
sion with retention of its affinity toward membranes. When
incubated with the apical membranes of MDCK cells, the
hydrophobic terminus of the positively charged peptides
apparently inserts into the membrane, assembles, and then
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functions in much the same way that the unmodified
M2GlyR did in artificial lipid membranes (Reddy et al.,
1993). Although increased solubilization was attained with
the addition of lysines to either terminus, many of the more
soluble species were still aggregated and did not interact
well with membranes. Only the C-K4-M2GlyR adduct,
which we believe formed a mixture of monomer and small
aggregates in aqueous systems, was able to substantially
increase short-circuit current and retain sensitivity to DPC
and bumetanide. Peptides with higher solubilities showed
decreased frequencies of channel formation, and those chan-
nels that did form appeared to lack the same ion selectivity
and pharmacology of the unmodified sequence (which we
tried to preserve). The ability to stimulate chloride and
water secretion in epithelial cells by using a small water-
soluble channel-forming peptide suggests a new method by
which a more normal phenotype can be restored to epithelial
cells in CF patients.
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